Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.
Year: 2000
Type: article
Source: PubMed
Authors: L N Klapper, H Waterman, M Sela, Y Yarden
Institution: Weizmann Institute of Science
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2148527073